Study | Period of Recruitment | Inception Cohort? No/Yes | No. Patients | Age, mean yrs | Disease Duration, mean yrs | RF (% positive) | ESR, mean mm/h |
---|---|---|---|---|---|---|---|
Vandenbroucke 19847 | 1954–1957 | N | 209 | 53.5 | 8 | 74 | 47 |
Wolfe 1994 (includes Wolfe, 1988 cohort)8 | 1955–1981 | N | 3501 | 53.3 | 9 | 88 | 45 |
Maradit Kremers 20059 | 1955–1995 | N | 603 | 58 | — | 59 | 47 |
Jacoby, 197310 | 1957–1963 | Y | 100 | 51 | 3 mo | 88 | 47 |
Gordon, 197311 | 1965–1966 | N | 127 | 55 | 11.5 | 93 | 66 |
Book 200512 | 1978–1978 | N | 152 | 61 | 12 | 85 | 43 |
Krause 200013 | 1980–1987 | N | 256 | 64.3 | 8.5 | 88 | 57 |
Wolfe 198814 | 1981–1985 | N | 400 | 54.8 | 9.5 | 80 | 37 |
Chehata 200115 | 1981–1985 | N | 309 | 53 | 2.5* | — | 45 |
Choi 200216 | 1981–1999 | N | 1240 | — | — | 83 | 34 |
Wolfe 200317 | 1981–1999 | N | 1387 | 55.5 | 7.1 | 85 | 41 |
Kremer 199718 | 1982–1983 | N | 29 | 60.6 | 31.4 | — | 36 |
Sokka 199919 | 1983–1989 | Y | 135 | 50.5 | 6.5 mo | 71 | 38 |
Maiden 199920 | 1984–1985 | N | 200 | 57* | 7* | — | 64* |
Callahan 199721 | 1984–1986 | N | 210 | 56.6 | 9.7 | — | 35 |
Lindqvist and Eberhardt 199922 | 1985–1989 | Y | 183 | 51 | 11 mo | 75 | 29* |
Kroot 200023 | 1985–1997 | Y | 622 | 53.3 | — | 82 | 41 |
Peltomaa 200224 | 1986–1993 | Y | 150 | 51.8 | 6.8 mo | 65 | 34* |
Soderlin 199825 | 1989–1991 | N | 103 | 59.5 | 18.4 | 88 | 27 |
Mattey 200726 | 1991–1991 | Y | 401 | 59.4 | 6 mo | 73 | 38* |
Nikolaisen 200827 | 1993–2000 | Y | 111 | 61* | 4.5 mo* | 78 | 41* |
Gonzalez-Gay 200728 | 1996–1996 | N | 182 | 59.7 | 10.5 | 78 | 28 |
Escalante 200529 | 1996–2000 | N | 779 | 55.6 | 11.1 | 79 | 42 |
↵* Median.